Skip to main content

Table 1 Patient characteristics in the two analysis populations

From: Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer

Characteristic

EORTC QLQ-C30

FACT-G

N = 903

N = 908

Age (years)

68 (58–74)

68 (58–74)

Sex

 Male

489 (54.2)

489 (53.9)

 Female

414 (45.8)

419 (46.1)

Hospitalization

 Yes

186 (20.6)

180 (20.8)

 No

717 (79.4)

719 (79.2)

ECOG performance status

 0

451 (49.9)

447 (49.2)

 1

368 (40.8)

377 (41.5)

 2

63 (7.0)

64 (7.0)

 3

20 (2.2)

19 (2.1)

 Unknown (0, 1, 2, or 3)

1 (0.1)

1 (0.1)

Tumor type

 Lung cancer

317 (35.1)

312 (34.4)

 Stomach cancer

65 (7.2)

64 (7.0)

 Colorectal cancer

222 (24.6)

226 (24.9)

 Breast cancer

113 (12.5)

116 (12.8)

 Other solid tumors

186 (20.6)

190 (20.9)

Stage at diagnosis

 I

49 (5.4)

48 (5.3)

 II

70 (7.8)

70 (7.7)

 III

184 (20.4)

185 (20.4)

 IV

588 (65.1)

593 (65.3)

 Unknown

12 (1.3)

12 (1.3)

Site of metastasis or recurrencea

 None

77 (8.5)

81 (8.9)

 Liver

198 (21.9)

204 (22.5)

 Lung

285 (31.6)

280 (30.8)

 Bone

160 (17.7)

165 (18.2)

 Brain

98 (10.9)

98 (10.8)

 Lymph nodes

361 (40.0)

361 (39.8)

 Others

225 (24.9)

227 (25.0)

History of surgery

 Yes

480 (53.2)

483 (53.2)

 No

422 (46.7)

424 (46.7)

 Unknown

1 (0.1)

1 (0.1)

Type of treatmenta

 Chemotherapy

582 (64.5)

590 (65.0)

 Endocrine therapy

65 (7.2)

66 (7.3)

 Molecular targeted therapy

159 (17.6)

158 (17.4)

 Immunotherapy

108 (12.0)

104 (11.5)

 Palliative therapy

35 (3.9)

37 (4.1)

 Others

8 (0.9)

8 (0.9)

  1. Median (IQR) is reported for age, whereas number (%) is reported for other characteristics
  2. EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; FACT-G, Functional Assessment of Cancer Therapy General; ECOG, Eastern Cooperative Oncology Group
  3. aMultiple choices are allowed